Hypothesis

11 Matching Annotations

Last 7 days
www.sciencedirect.com www.sciencedirect.com

Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells

1
1. scibot 30 Aug 2025
  
  in Public
  
  RRID:AB_2561952
  
  DOI: 10.1016/j.xcrm.2025.102321
  
  Resource: (BioLegend Cat# 338312, RRID:AB_2561952)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2561952
  
  What is this?
  
  RRID:AB_2561952
Visit annotations in context

Tags

RRID:AB_2561952

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125003945
Aug 2025
www.sciencedirect.com www.sciencedirect.com

Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells

1
1. scibot 13 Aug 2025
  
  in Public
  
  RRID:AB_2561952
  
  DOI: 10.1016/j.medj.2025.100804
  
  Resource: (BioLegend Cat# 338312, RRID:AB_2561952)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2561952
  
  What is this?
  
  RRID:AB_2561952
Visit annotations in context

Tags

RRID:AB_2561952

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666634025002314
May 2025
www.sciencedirect.com www.sciencedirect.com

Protocol to generate allorejection-resistant universal CAR-NKT cells and evaluate their efficacy, mechanism of action, safety, and immunogenicity

1
1. scibot 19 May 2025
  
  in Public
  
  RRID:AB_2561952
  
  DOI: 10.1016/j.xpro.2025.103810
  
  Resource: (BioLegend Cat# 338312, RRID:AB_2561952)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2561952
  
  What is this?
  
  RRID:AB_2561952
Visit annotations in context

Tags

RRID:AB_2561952

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666166725002163
Apr 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Protocol to profile tumor and microenvironment from ovarian cancer patient samples and evaluate cell-based therapy using in vitro killing assays

1
1. scibot 18 Apr 2025
  
  in Public
  
  RRID:AB_2561952
  
  DOI: 10.1016/j.xpro.2025.103742
  
  Resource: (BioLegend Cat# 338312, RRID:AB_2561952)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2561952
  
  What is this?
  
  RRID:AB_2561952
Visit annotations in context

Tags

RRID:AB_2561952

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12002649/
Mar 2025
www.sciencedirect.com www.sciencedirect.com

Monocytes from patients with myelodysplastic syndrome inhibit natural killer cell-mediated antitumor function through the CD200/CD200R pathway

1
1. scibot 06 Mar 2025
  
  in Public
  
  RRID:AB_2561952
  
  DOI: 10.1016/j.intimp.2025.114394
  
  Resource: (BioLegend Cat# 338312, RRID:AB_2561952)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2561952
  
  What is this?
  
  RRID:AB_2561952
Visit annotations in context

Tags

RRID:AB_2561952

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1567576925003844
Jan 2025
www.nature.com www.nature.com

Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture

1
1. scibot 31 Jan 2025
  
  in Public
  
  RRID:AB_2561952
  
  DOI: 10.1038/s41596-024-01077-w
  
  Resource: (BioLegend Cat# 338312, RRID:AB_2561952)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2561952
  
  What is this?
  
  RRID:AB_2561952
Visit annotations in context

Tags

RRID:AB_2561952

Annotators

scibot

URL

nature.com/articles/s41596-024-01077-w
Oct 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design

2
1. scibot 11 Oct 2023
  
  in Public
  
  RRID:AB_2561952
  
  DOI: 10.1016/j.isci.2023.107952
  
  Resource: (BioLegend Cat# 338312, RRID:AB_2561952)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2561952
  
  What is this?
  
  RRID:AB_2561952
2. scibot 01 Oct 2023
  
  in Public
  
  RRID:AB_2561952
  
  DOI: 10.1016/j.isci.2023.107952
  
  Resource: (BioLegend Cat# 338312, RRID:AB_2561952)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2561952
  
  What is this?
  
  RRID:AB_2561952
Visit annotations in context

Tags

RRID:AB_2561952

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10558812/
Aug 2022
www.sciencedirect.com www.sciencedirect.com

Off-The-Shelf Third-Party HSC-Engineered iNKT Cells for Ameliorating GvHD While Preserving GvL Effect in the Treatment of Blood Cancers

1
1. scibot 17 Aug 2022
  
  in Public
  
  RRID:AB_2561952
  
  DOI: 10.1016/j.isci.2022.104859
  
  Resource: (BioLegend Cat# 338312, RRID:AB_2561952)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2561952
  
  What is this?
  
  RRID:AB_2561952
Visit annotations in context

Tags

RRID:AB_2561952

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004222011312
Nov 2021
www.sciencedirect.com www.sciencedirect.com

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

1
1. scibot 17 Nov 2021
  
  in Public
  
  RRID:AB_2561952
  
  DOI: 10.1016/j.xcrm.2021.100449
  
  Resource: (BioLegend Cat# 338312, RRID:AB_2561952)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2561952
  
  What is this?
  
  RRID:AB_2561952
Visit annotations in context

Tags

RRID:AB_2561952

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379121003177
May 2021
www.sciencedirect.com www.sciencedirect.com

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy

1
1. scibot 06 May 2021
  
  in Public
  
  RRID:AB_2561952
  
  DOI: 10.1016/j.immuni.2020.09.006
  
  Resource: (BioLegend Cat# 338312, RRID:AB_2561952)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2561952
  
  What is this?
  
  RRID:AB_2561952
Visit annotations in context

Tags

RRID:AB_2561952

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1074761320304003